Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

• New research from France suggests that stopping cholesterol-lowering statins at age 75 may be harmless for patients with no history of cardiovascular disease. • A separate Duke University study confirms that the real-world safety and effectiveness of the Alzheimer’s drug lecanemab (Leqembi) align with its original clinical trial data.

• A new study published June 2, 2026, reveals that the type of dietary fat consumed significantly impacts pancreatic cancer progression. • Researchers discovered that oleic acid, primarily found in olive oil, helped reduce the disease by half, while other fats promoted tumor growth.

• Prescriptions for leucovorin surged in the US following a September 2025 White House press conference that suggested the drug as a treatment for autism. • A study published in The New England Journal of Medicine (NEJM) highlights that this increase occurred despite a lack of supporting clinical data for such use.

• Associate Professor Damali Campbell-Oparali of Rutgers New Jersey Medical School is addressing the systemic drivers behind maternal health disparities affecting Black mothers. • The discussion focuses on the specific challenges Black women navigate during pregnancy and the postpartum period to identify gaps in care.

• Donald Trump has issued orders directing the Department of Justice to target states and localities whose childhood immunization rules conflict with parental authority, religious freedom, and medical exemptions. • The orders include a call for the CDC to revise its vaccine recommendations to align with those of other developed nations and revive claims linking vaccines to autism, despite scientific refutation.

• The CDC has reported over 24,000 cases of cyclosporiasis across 47 states, linked to an outbreak caused by contaminated shredded iceberg lettuce. • The illness is caused by Cyclospora cayetanensis, a unicellular parasite that leads to an intestinal infection in humans.

• Pharmaceutical journalist Maryanne Demasi has uncovered significant anomalies in the trial data for mRNA vaccines. • The findings, sourced from the FDA's depository and the New England Journal of Medicine, suggest the trials relied on questionable assumptions and imprecisions.

• Indian scientists have developed light-driven nanobots designed to enhance the treatment of breast cancer. • These nanobots are activated by near-infrared (NIR) light and respond to specific biological triggers, including glutathione levels and pH.

• An Ebola outbreak in the Democratic Republic of Congo has escalated, resulting in more than 2,000 deaths. • Infectious disease experts emphasize that the average American faces very little domestic risk from the virus.

• U.S. poison centers have seen a nearly fourfold increase in calls regarding liver injury between 2000 and 2024, with acetaminophen (Tylenol) identified as the primary cause. • Definium Therapeutics announced that its phase III trial for an investigational LSD pill successfully met its primary endpoint in treating generalized anxiety disorder.

• The WHO chief warns that the current Ebola outbreak in the east of DR Congo, declared on 15 May, is on track to be the deadliest ever. • The virus has already caused over 2,000 deaths, with thousands more cases reported and no approved vaccines or therapeutic drugs available for this specific strain.